Results 81 to 90 of about 19,141 (206)

A case of cardiac sarcoidosis presenting with double tachycardia

Journal of Arrhythmia, 2015
Although the most feared cardiac manifestation in cardiac sarcoidosis is the onset of ventricular arrhythmia, some patients may present with supraventricular arrhythmias.
Keiko Takahashi, MD, Yasuo Okumura, MD, Ichiro Watanabe, MD, Koichi Nagashima, MD, Hiroaki Mano, MD, Kazumasa Sonoda, MD, Rikitake Kogawa, MD, Naoko Sasaki, MD, Kazuki Iso, MD, Kimie Okubo, MD, Toshiko Nakai, MD, Atsushi Hirayama, MD   +11 more
doaj   +1 more source

Risk of Adverse Outcomes Associated With Cardiac Sarcoidosis Diagnostic Schemes

, 2023
Rahul Myadam, Thomas Crawford, Frank Bogun, Xiaokui Gu, Kenneth A. Ellenbogen, Shilpa Jasti, Alexandru B. Chicos, Henri Roukoz, Peter Zimetbaum, Steven J. Kalbfleisch, Francis Murgatroyd, David Steckman, Lynda E. Rosenfeld, Ann C. Garlitski, Kyoko Soejima, Adarsh Bhan, Vasanth Vedantham, Timm‐Michael Dickfeld, David B. De Lurgio, Pyotr G. Platonov, Matthew M. Zipse, Suguru Nishiuchi, Matthew Ortman, Calambur Narasimhan, Kristen K. Patton, David G. Rosenthal, Siddharth S. Mukerji, Jarieke C. Hoogendoorn, Katja Zeppenfeld, William H. Sauer, Jordana Kron   +30 more
openalex   +2 more sources

Great mimicker: definite isolated cardiac sarcoidosis masquerading as hypertrophic cardiomyopathy [PDF]

, 2023
Tuan Pham, Jacob A. Abraham, Farooq H. Sheikh   +2 more
openalex   +1 more source

P1603Efficacy of combination therapy of methotrexate and low-dose corticosteroid for cardiac sarcoidosis evaluated by fuluorine-18 fluorodeoxyglucose positron emission tomography [PDF]

, 2018
Takafumi Yokomatsu, S. Hojo, Tetsuma Kawaji, Akihiro Kushiyama, Kenji Nakatsuma, Kazuhisa Kaneda, Masashi Kato, S Miki   +7 more
openalex   +1 more source

Semi-quantitative metabolic values on FDG PET/CT including extracardiac sites of disease as a predictor of treatment course in patients with cardiac sarcoidosis

EJNMMI Research, 2017
Background Cardiac sarcoidosis is associated with major adverse cardiac events including cardiac arrest, for which anti-inflammatory treatment is indicated. Oral corticosteroid is the mainstay among treatment options; however, adverse effects are a major
Mitsutomi Ishiyama, Laurie A. Soine, Hubert J. Vesselle   +2 more
doaj   +1 more source

Cardiac sarcoidosis [PDF]

BMJ, 1997
D N, Mitchell, R M, du Bois, P J, Oldershaw   +2 more
openaire   +4 more sources

Cardiac sarcoidosis presenting as recurrent ventricular tachycardia: a case report [PDF]

, 2009
Mir Yasir, Imran Masood, Aiffa Aiman, Sheikh Afaq, Ashok Bakaya   +4 more
openalex   +1 more source

Localization of Late Gadolinium Enhancement and Its Association with Ventricular Tachycardia in Patients with Cardiac Sarcoidosis

, 2022
Kenji Yodogawa, Yoshimitsu Fukushima, Masaki Tachi, Yuhi Fujimoto, K. Hagiwara, Eiichiro Oka, Hiroshi Hayashi, Hiroshige Murata, Teppei Yamamoto, Yu‐ki Iwasaki, Yasuo Amano, Shin‐ichiro Kumita, Wataru Shimizu   +12 more
openalex   +2 more sources

[Cardiac sarcoidosis].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2018
Sarcoidosis is characterised by granulomatous inflammation in one or more organs, including the heart. Cardiac sarcoidosis generally has non-specific symptoms, and the disease is often diagnosed at a late stage. The condition is associated with cardiomyopathy and arrhythmia and may be fatal.
Jens, Vikse, Stein, Ørn, Bas, Jeroen de Romijn, Ole Jacob, Greve, Katrine Brække, Norheim   +4 more
openaire   +1 more source

P5406Is it safe to discontinue immunosuppression in cardiac sarcoidosis? [PDF]

, 2017
Piia Simonen, Jukka Lehtonen, Markku Kupari   +2 more
openalex   +1 more source